Clinical Trial Update: Safety of SCH 530348 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention (Study P03573) [Phase 2]

View source ↗

Summary

A Phase 2 safety update on SCH 530348 (vorapaxar) in patients undergoing non-emergent percutaneous coronary intervention (Study P03573), with the trial status m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Peripheral Artery Disease

Drugs mentioned

• Vorapaxar (vorapaxar)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Arterial Obstructive Diseases, Coronary Disease | Phase 2 | Status: COMPLETED